Bell Potter maintains a buy rating on MedAdvisor (ASX:MDR) and...

  1. 4,217 Posts.
    lightbulb Created with Sketch. 238
    Bell Potter maintains a buy rating on MedAdvisor (ASX:MDR) and has a 12-month price target of $0.64. The buy rating is maintained by Bell Potter following another strong quarter of topline growth in the US, Australia and New Zealand, while gross margins also improved. Q4 revenue was up 32% on the previous corresponding period with full-year revenue up 25%, hence the buy rating is maintained.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.8¢
Change
-0.001(1.27%)
Mkt cap ! $48.73M
Open High Low Value Volume
7.6¢ 7.8¢ 7.5¢ $68.98K 890.5K

Buyers (Bids)

No. Vol. Price($)
5 240645 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 27812 1
View Market Depth
Last trade - 16.10pm 25/06/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.